Mziya I. Makieva

Mziya I. Makieva

Auto-generated profile, based on publicly available information

Mziya I. Makieva

V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology and Perinatology

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2022 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
YKYuliya Kosolapova
Yuliya Kosolapova
BBBoris D.A. Boris
Boris D.A. Boris
PPPoludenko N.D. Poludenko
Poludenko N.D. Poludenko
MMMakieva M.I. Makieva M
Makieva M.I. Makieva M
NNNikitina I.V. Nikitina
Nikitina I.V. Nikitina
DDDegtyarev D.N. Degtyarev
Degtyarev D.N. Degtyarev

5 March 2024 in Journal of Modern Oncology
Verified
Journal Article
Open access
PDF file
OLOlga B. Ladodo
Olga B. Ladodo
MIMariia Iurova
Mariia Iurova
SKSvetlana V. Khokhlova
Svetlana V. Khokhlova
VRValery Vitalievich Rodionov
Valery Vitalievich Rodionov
ESElena L. Sheshko
Elena L. Sheshko
ЮВЮрова Мария Владимировна
Юрова Мария Владимировна
In the modern world breastfeeding (BF) is considered as a significant factor in reducing the risk of developing malignant tumors of the mammary gland and ovaries. However, the problem of maintenance or refusing BF in malignant neoplasms (malignant neoplasms) still remains open. In recent years, there has been a steady increase in breast cancer (BC), especially in developed countries, with more than 10% of all breast malignancies (BC) diagnosed in women under 40 years of age. The presented article highlights aspects of maintaining lactation in different periods of the relevance of BF in relation to the timing of manifestation of cancer, and also presents data from the multicenter study POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer) on the possibilities of implementing reproductive function and BF in women receiving therapy for hormone-receptor positive (HR+) BC stages I–III. BF with cancer detected in the postpartum period depends on the treatment of the underlying disease. In patients undergoing surgical treatment, BF is not contraindicated, but it is not always technically possible. During chemotherapy, BF is not recommended. When carrying out radiotherapy, it is possible to undergo BF using a healthy mammary gland. There is currently no evidence to suggest that BF woman diagnosed with cancer may have any negative effects. In general, it has been shown that preserving and maintaining lactation in women with a history of cancer is safe for both mother and child.

1 January 2024 in Neonatology: News, Opinions, Training
Verified
Journal Article
Open access
LTL.A. Timofeeva
L.A. Timofeeva
AKA.L. Karavaeva
A.L. Karavaeva
MMM.I. Makieva
M.I. Makieva
VZV.V. Zubkov
V.V. Zubkov
IRI.I. Ryumina
I.I. Ryumina
DDD.N. Degtyarev
D.N. Degtyarev
Базовая помощь доношенному новорожденному в родильном зале и объем мероприятий в послеродовом отделении. Обновленные рекомендации, 2024

1 January 2023 in Neonatology: News, Opinions, Training
Verified
Journal Article
Open access
EAE.S. Akhapkina
E.S. Akhapkina
MMM.I. Makieva
M.I. Makieva
SKS.V. Khokhlova
S.V. Khokhlova
VZV.V. Zubkov
V.V. Zubkov
OLO.B. Ladodo
O.B. Ladodo
Особенности состояния здоровья детей, рожденных у матерей с раком молочной железы во время беременности: обзор литературы

1 January 2024 in Doctor.Ru
Verified
Journal Article
Open access
EBE.L. Bokerija
E.L. Bokerija
RMRussian Federation Moscow
Russian Federation Moscow
OSO.V. Shumakova
O.V. Shumakova
AKA.L. Karavaeva
A.L. Karavaeva
LTL.A. Timofeeva
L.A. Timofeeva
VZV.V. Zubkov
V.V. Zubkov
Aim. To evaluate screening methods for critical congenital heart defects (CHD), in particular obstructive aortic arch defects (OАADs), using dual-zone systolic blood pressure (SBP) and oxygen saturation measurements in healthy newborns. Design. A prospective observational study. Material and methods. The study included 12 098 healthy newborns aged 48 (36–50) hours of life, who were screened for critical CHDs using dual-zone measurements of SBP and saturation, as well as using physical methods. Screening for critical CHDs was considered normal if the saturation difference was 2% or less, the saturation was more than 95%, the difference in SBP was 9 mm Hg and less. If the screening was abnormal, echocardiography (ECHO-CG) was performed. The end point of the study was to determine the sensitivity and specificity of screening for OPAADs in healthy newborns using dual-zone measurement of SBP and saturation. Results. 12 037 children had normal screening results. In these children, the difference in pre- and postductal SBP was 0 (standard deviation (σ) = 4.26 mm Hg, and the difference (Me) in saturation was 0 (σ = 0.93%). Dual-zone SBP screening was abnormal in 34 newborns. The difference in their SBP was 11 (10–34) mm Hg. In 16 of these children ECHO-CG did not reveal CHD, and in 4 — critical OAADs — coarctation of aorta was diagnosed. A decrease in peripheral pulsation in the femoral arteries was noted only in children with critical OAADs. Pulse oximetry screening was normal in these children with critical OAADs. Dual-zone saturation screening was abnormal in 16 children. The difference in saturation between them was 3 (3–5)%. In 13 of these children, ECHO-CG did not reveal CHDs, and in 1 child critical CHD was diagnosed — transposition of the great arteries. Also, this child (and another who was healthy) had a decrease in saturation of less than 95%. In 11 newborns, screening was abnormal only due to saturation of 95% or less, but ECHO-CG did not reveal CHDs. The sensitivity and specificity of screening for OAADs using dual-zone SBP measurement was 100 and 80%, and using dual-zone pulse oximetry was 0 and 73.6%, respectively. Conclusions. In newborns with OAADs, a difference in SBP of 10 mmHg is recorded after 36 hours of their life. Dual-zone measurement of SBP is the most highly sensitive and specific method for detecting OAADs in comparison with dual-zone pulse oximetry. Dual-zone measurement of SBP and determination of peripheral pulsation are recommended for inclusion in the neonatal screening protocol for critical CHDs. Keywords: congenital heart disease, neonatal screening for congenital heart defects, aortic coarctation, aortic arch interruption, blood pressure.

1 January 2024 in Doctor.Ru
Verified
Journal Article
Open access
EAE.S. Akhapkina
E.S. Akhapkina
RMRussian Federation Moscow
Russian Federation Moscow
LAL.M. Azueva
L.M. Azueva
MMM.I. Makieva
M.I. Makieva
EPEvgeniya Polushkina
Evgeniya Polushkina
VZV.V. Zubkov
V.V. Zubkov
Aim. To evaluate the impact of changes in the treatment of pregnancy with breast cancer on the condition and characteristics of the newborn. Design. Retrospective prospective cohort study. Materials and methods. Evaluation and comparison of data on pregnancy management and characteristics of the condition and management of newborns in two groups. The first group consisted of 68 newborns born to mothers with breast cancer from 2013 to 2019, data from medical records were collected and analyzed retrospectively. The second (prospective) group included 75 children born to mothers with breast cancer during pregnancy from 2020 to 2023. The study was conducted on the basis of the department of newborn National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov. Results. The study groups differed statistically in the dates of pregnancy at the time of delivery, which is due to the changed treatment of patients with breast cancer during pregnancy. In the prospective group significantly more children (61 (81.3%) child) were born pregnant (p < 0.05). The absolute majority of pregnancies in a prospective cohort of patients determined differences in the condition and behavior of newborns. Thus, in the first group of children, the duration of hospital treatment after birth was significantly shorter than in the second (4 and 7 days respectively, p = 0.000). In the prospective group with the diagnosis «Healthy» 41 (54.7%) children were discharged from the maternity hospital, in the retrospective group only 9 (13.2%) children (Yates correction, p < 0.05).